Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00478894 · ClinicalTrials.gov registry record
Multicenter Orthopaedic Outcomes Network (MOON) ACL Reconstruction (ACLR): Onsite Follow-up
A clinical trial, sponsored by Vanderbilt University.
- Completed
- Registry status
- 432
- Enrollment target
NCT00478894: Completed study, sponsored by Vanderbilt University.
NCT00478894 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 432 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00478894 has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 432 participants
- Enrollment target
Study Summary
In this study we will examine patients who have undergone unilateral ACL reconstruction surgery to determine which structural and functional characteristics of the knee two and ten years post reconstruction surgery, aspects of the original injury and repair, and patient characteristics are risk factors for osteoarthritis after ACL reconstruction surgery.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 432 participants |
| Start Date | 2007-08 |
| Est. Completion | 2025-12 |
What the finished NCT00478894 record still lists
NCT00478894 is an observational study that tracks outcomes without assigning an intervention. The registered 432 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00478894 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00478894 about?
NCT00478894 is a clinical study titled "Multicenter Orthopaedic Outcomes Network (MOON) ACL Reconstruction (ACLR): Onsite Follow-up". In this study we will examine patients who have undergone unilateral ACL reconstruction surgery to determine which structural and functional characteristics of the knee two and ten years post reconstruction surgery, aspects of the original injury and repair, and patient characteristics are risk fact...
What is the current status of trial NCT00478894?
This trial is currently completed. The enrollment target is 432 participants. The study started on 2007-08. Estimated completion is 2025-12.
Who is sponsoring clinical trial NCT00478894?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05271240 · 432 participants · Phase 3
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
- NCT05365815 · 432 participants · NA
Melanated Group Midwifery Care (MGMC)
- NCT05499507 · 432 participants · NA
The Path to Optimal Black Maternal Heart Health: Comparing Two CVD Risk Reduction Interventions (Change of HEART)
- NCT05806164 · 432 participants · Phase 4
Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia